Dr. Ronald R. Romero

Ronald D. Chervin, M.D., M.S. - Michael S. Aldrich Collegiate Professor of Sleep Medicine, Professor of Neurology, and Director, Sleep Disorders Center. Dr. Chervin completed his medical degree at Stanford University, and a master's degree in clinical research at the University of Michigan School of Public Health. He completed a residency in neurology at Cornell University in New York City, and a fellowship in sleep medicine at Stanford University.Dr. Chervin's clinical and research interests focus on both adults and children. He has contributed to research on a wide range of subjects in sleep medicine, including obstructive sleep apnea, upper airway resistance syndrome, sleep laboratory methods, sleepiness, insomnia, cognitive and behavioral consequences of sleep disorders, periodic leg movements during sleep, and REM sleep behavior disorder. Dr. Chervin is highly rated in 10 conditions, according to our data. His top areas of expertise are Obstructive Sleep Apnea, Restless Legs Syndrome, Central Sleep Apnea, Drowsiness, and Adenoidectomy.

Dr. Shelley Hershner, M.D., is an Associate Professor of Neurology, Division of Sleep Medicine at the University of Michigan and the Director of the Collegiate Sleep Disorders Clinic. After earning her medical degree from the Medical College of Ohio, she completed a neurology residency and a sleep medicine fellowship at the University of Michigan. Dr. Hershner's research focuses on the intersection of academics and sleep issues among college students, as well as sleep disorders in transgender individuals. She has extensive experience managing narcolepsy and idiopathic hypersomnia and has authored numerous scientific papers and book chapters in her field. Dr. Hershner is highly rated in 10 conditions, according to our data. Her top areas of expertise are Drowsiness, Restless Legs Syndrome, Excessive Daytime Sleepiness, and Narcolepsy.

Henry L. Paulson, M.D., Ph.D., is the Lucile Groff Professor of Neurology for Alzheimer's Disease and Related Disorders in the Department of Neurology at the University of Michigan. Dr. Paulson joined the U-M faculty in 2007, and he currently directs the Michigan Alzheimer’s Disease Center (MADC) and co-direct the U-M Protein Folding Diseases Initiative.Dr. Paulson received his medical degree and doctorate in Cell Biology from Yale University in 1990. He then completed a neurology residency and neurogenetics/movement disorders fellowships at the University of Pennsylvania. In 1997, he joined the Neurology faculty at the University of Iowa, where he remained until 2007.Dr. Paulson's research and clinical interests concern the causes and treatment of age-related neurodegenerative diseases, with an emphasis on polyglutamine diseases, Alzheimer's disease and frontotemporal dementia. In 1997, his lab described abnormal protein aggregates in the polyglutamine diseases, which now are recognized as a pathological hallmark in this important class of inherited diseases. Using test tube, cell-based and animal models, he has contributed to advances in the understanding of various neurodegenerative diseases. His lab also has helped pioneer the use of gene silencing methods as potential therapy for the many neurological disorders caused by toxic mutant genes.Nationally, Dr. Paulson has directed popular courses at the American Academy of Neurology meetings, serves on the scientific advisory boards of numerous disease-related national organizations, and is past Chair of the Board of Scientific Counselors at the National Institute for Neurological Disorders and Stroke at the National Institutes of Health.Among his awards, Dr. Paulson is an Ellison Medical Foundation New Scholar in Aging, a semifinalist for the W.M. Keck Foundation Young Scholars in Medical Research, and a recipient of the Paul Beeson Physician Faculty Scholar in Aging Award from the American Federation for Aging Research. Dr. Paulson is highly rated in 41 conditions, according to our data. His top areas of expertise are Olivopontocerebellar Atrophy, Spinocerebellar Ataxia Type 3, Spinocerebellar Ataxia, and Drug Induced Dyskinesia.